Cocrystal Pharma Quick Ratio 2008-2020 | COCP

Historical quick ratio values for Cocrystal Pharma (COCP) over the last 10 years.
Cocrystal Pharma Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-09-30 $0.00B $0.00B 0.00
2020-06-30 $0.00B $0.00B 0.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.00B $0.00B 0.00
2019-09-30 $0.00B $0.00B 0.00
2019-06-30 $0.00B $0.00B 0.00
2019-03-31 $0.00B $0.00B 0.00
2018-12-31 $0.00B $0.00B 0.00
2018-09-30 $0.00B $0.00B 0.00
2018-06-30 $0.00B $0.00B 0.00
2018-03-31 $0.00B $0.00B 0.00
2017-12-31 $0.00B $0.00B 0.00
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.00B 0.00
2016-03-31 $0.00B $0.01B 0.00
2015-12-31 $0.00B $0.01B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.02B 0.00
2014-12-31 $0.00B $0.01B 0.00
2014-09-30 $0.00B $0.01B 0.00
2014-06-30 $0.00B $0.01B 0.00
2014-03-31 $0.00B $0.01B 0.00
2013-12-31 $0.00B $0.00B 0.00
2013-09-30 $0.00B $0.02B 0.07
2013-06-30 $0.00B $0.01B 0.17
2013-03-31 $0.00B $0.01B 0.09
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B $0.01B 0.28
2012-06-30 $0.00B $0.01B 0.20
2012-03-31 $0.00B $0.01B 0.14
2011-12-31 $0.00B $0.01B 0.15
2011-09-30 $0.00B $0.01B 0.34
2011-06-30 $0.00B $0.01B 0.48
2011-03-31 $0.00B $0.00B 0.00
2010-12-31 $0.00B $0.01B 0.33
2010-09-30 $0.00B $0.00B 0.00
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.00B $0.00B 0.00
2008-06-30 $0.00B $0.00B 0.00
2008-03-31 $0.00B 0.00
2007-09-30 $0.00B 0.00
2007-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.148B $0.007B
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of HepC. Phase 1b studies in HepC infected patients showed the largest reduction in viral load of any non-nucleoside inhibitor tested to date. The next step for CC-31244 is clinical trials as part of a cocktail for ultra-short therapy of 2 to 6 weeks. The lead candidate for influenza has advanced to IND-enabling studies. It is effective in animal models against both the pandemic and seasonal strains of influenza. In addition, the Company has a pipeline of promising early preclinical programs. Two private investors own approximately 48% of the Company.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.192B 10.06
Amgen (AMGN) United States $129.265B 13.51
CSL (CSLLY) Australia $100.321B 0.00
Gilead Sciences (GILD) United States $76.052B 10.11
Moderna (MRNA) United States $60.441B 0.00
Vertex Pharmaceuticals (VRTX) United States $59.224B 27.54
Regeneron Pharmaceuticals (REGN) United States $55.064B 19.53
Illumina (ILMN) United States $47.025B 64.68
Biogen (BIIB) United States $36.958B 6.57
Seagen (SGEN) United States $30.708B 81.10
BioNTech SE (BNTX) Germany $28.111B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.723B 10.65
Genmab (GMAB) Denmark $25.307B 29.93
Genmab (GNMSF) Denmark $23.353B 5.38
BeiGene (BGNE) Cayman Islands $23.216B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $18.514B 0.00
Exact Sciences (EXAS) United States $18.210B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.122B 61.14
Horizon Therapeutics Public (HZNP) Ireland $15.545B 22.22
Alnylam Pharmaceuticals (ALNY) United States $15.093B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.286B 94.82
ARGENX SE-ADR (ARGX) Netherlands $13.483B 0.00
Guardant Health (GH) United States $12.109B 0.00
Mirati Therapeutics (MRTX) United States $11.959B 0.00
Bio-Techne Corp (TECH) United States $11.711B 74.89
Sarepta Therapeutics (SRPT) United States $11.116B 0.00
QIAGEN (QGEN) Netherlands $10.991B 24.75
Repligen (RGEN) United States $9.980B 141.54
Ascendis Pharma (ASND) Denmark $9.013B 0.00
ACADIA Pharmaceuticals (ACAD) United States $9.008B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.967B 0.00
Novavax (NVAX) United States $8.881B 0.00
Galapagos (GLPG) Belgium $8.011B 0.00
Denali Therapeutics (DNLI) United States $7.311B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.236B 0.00
Acceleron Pharma (XLRN) United States $7.114B 0.00
Adaptive Biotechnologies (ADPT) United States $6.595B 0.00
Blueprint Medicines (BPMC) United States $6.023B 19.94
Amicus Therapeutics (FOLD) United States $5.965B 0.00
Exelixis (EXEL) United States $5.944B 39.92
SWEDISH ORP BIO (BIOVF) Sweden $5.355B 14.63
Halozyme Therapeutics (HALO) United States $5.286B 244.38
NeoGenomics (NEO) United States $5.283B 1586.00
Reata Pharmaceuticals (RETA) United States $5.175B 0.00
Fate Therapeutics (FATE) United States $5.101B 0.00
Twist Bioscience (TWST) United States $5.045B 0.00
China Biologic Products (CBPO) China $4.684B 30.35
Emergent Biosolutions (EBS) United States $4.342B 14.25
Vir Biotechnology (VIR) United States $4.061B 0.00
Insmed (INSM) United States $3.974B 0.00
Legend Biotech (LEGN) United States $3.842B 0.00
Arena Pharmaceuticals (ARNA) United States $3.831B 0.00
MorphoSys AG (MOR) Germany $3.682B 133.29
Eidos Therapeutics (EIDX) United States $3.559B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.518B 0.00
Bluebird Bio (BLUE) United States $2.926B 0.00
Alkermes (ALKS) Ireland $2.906B 28.53
Beam Therapeutics (BEAM) United States $2.898B 0.00
Global Blood Therapeutics (GBT) United States $2.837B 0.00
Seres Therapeutics (MCRB) United States $2.519B 0.00
Zymeworks (ZYME) Canada $2.413B 0.00
Intellia Therapeutics (NTLA) United States $2.320B 0.00
Alcobra (ARCT) United States $2.247B 0.00
I-Mab (IMAB) China $2.233B 0.00
PHARMA MAR SA (PHMMF) Spain $2.161B 0.00
Sorrento Therapeutics (SRNE) United States $2.156B 0.00
UniQure (QURE) Netherlands $2.139B 0.00
Viela Bio (VIE) United States $2.102B 0.00
Inovio Pharmaceuticals (INO) United States $2.070B 0.00
Amarin (AMRN) Ireland $1.940B 0.00
Editas Medicine (EDIT) United States $1.907B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Intra-Cellular Therapies (ITCI) United States $1.895B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.800B 0.00
Mesoblast (MESO) Australia $1.770B 0.00
Arcus Biosciences (RCUS) United States $1.768B 0.00
Mersana Therapeutics (MRSN) United States $1.745B 0.00
Scholar Rock Holding (SRRK) United States $1.676B 0.00
NGM Biopharmaceuticals (NGM) United States $1.636B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Revance Therapeutics (RVNC) United States $1.607B 0.00
Zealand Pharma (ZEAL) Denmark $1.533B 0.00
Precigen (PGEN) United States $1.469B 0.00
Sangamo Therapeutics (SGMO) United States $1.413B 0.00
Epizyme (EPZM) United States $1.396B 0.00
Ligand Pharmaceuticals (LGND) United States $1.357B 35.15
Coherus BioSciences (CHRS) United States $1.330B 8.79
Adverum Biotechnologies (ADVM) United States $1.325B 0.00
Myriad Genetics (MYGN) United States $1.319B 0.00
REGENXBIO (RGNX) United States $1.303B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Athenex (ATNX) United States $1.272B 0.00
Genetron Holdings (GTH) China $1.209B 0.00
Cytokineticsorporated (CYTK) United States $1.189B 0.00
Heska (HSKA) United States $1.182B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.172B 0.00
Travere Therapeutics (TVTX) United States $1.171B 0.00
Vericel (VCEL) United States $1.160B 0.00
Northwest Biotherapeutics (NWBO) United States $1.145B 0.00
Codexis (CDXS) United States $1.098B 0.00
Cellectis S.A (CLLS) France $1.078B 0.00
NantKwest (NK) United States $1.040B 0.00
Alector (ALEC) United States $1.039B 0.00
Arvinas (ARVN) United States $0.981B 0.00
Pliant Therapeutics (PLRX) United States $0.976B 0.00
Morphic Holding (MORF) United States $0.976B 0.00
Frequency Therapeutics (FREQ) United States $0.968B 0.00
Castle Biosciences (CSTL) United States $0.947B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.947B 0.00
Protagonist Therapeutics (PTGX) United States $0.924B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.903B 0.00
Celldex Therapeutics (CLDX) United States $0.890B 0.00
Pharming Group (PHGUF) Netherlands $0.889B 20.29
Compugen (CGEN) Israel $0.879B 0.00
Cardiff Oncology (CRDF) United States $0.873B 0.00
VBI Vaccines (VBIV) United States $0.829B 0.00
Kadmon Holdings (KDMN) United States $0.748B 0.00
MiMedx (MDXG) United States $0.745B 0.00
Cara Therapeutics (CARA) United States $0.731B 0.00
Five Prime Therapeutics (FPRX) United States $0.715B 0.00
Albireo Pharma (ALBO) United States $0.710B 0.00
AnaptysBio (ANAB) United States $0.705B 0.00
Agenus (AGEN) United States $0.704B 0.00
MannKind (MNKD) United States $0.693B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.668B 33.92
Sutro Biopharma (STRO) United States $0.660B 0.00
Precision BioSciences (DTIL) United States $0.654B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.652B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.638B 0.00
IVERIC Bio (ISEE) United States $0.611B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.600B 0.00
Geron (GERN) United States $0.579B 0.00
Dynavax Technologies (DVAX) United States $0.560B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.548B 0.00
MeiraGTx Holdings (MGTX) United States $0.542B 0.00
Anika Therapeutics (ANIK) United States $0.537B 72.69
Aquinox Pharmaceuticals (NLTX) United States $0.532B 0.00
Avid Bioservices (CDMO) United States $0.516B 0.00
Merus (MRUS) Netherlands $0.498B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.493B 0.00
Cel-Sci (CVM) United States $0.483B 0.00
Prothena (PRTA) Ireland $0.452B 0.00
Forte Biosciences (FBRX) United States $0.451B 0.00
Spero Therapeutics (SPRO) United States $0.451B 0.00
Puma Biotechnology (PBYI) United States $0.447B 0.00
Clovis Oncology (CLVS) United States $0.435B 0.00
UROGEN PHARMA (URGN) United States $0.434B 0.00
WAVE Life Sciences (WVE) Singapore $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.429B 0.00
Cue Biopharma (CUE) United States $0.423B 0.00
Innate Pharma S.A (IPHA) France $0.422B 0.00
Kala Pharmaceuticals (KALA) United States $0.418B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.416B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Affimed (AFMD) Germany $0.407B 0.00
AC Immune SA (ACIU) Switzerland $0.397B 0.00
Trevena (TRVN) United States $0.394B 0.00
Starpharma Holdings (SPHRY) Australia $0.387B 0.00
Arbutus Biopharma (ABUS) United States $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 18.09
Bicycle Therapeutics (BCYC) United Kingdom $0.378B 0.00
Syros Pharmaceuticals (SYRS) United States $0.373B 0.00
Athersys (ATHX) United States $0.366B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 9.30
XOMA (XOMA) United States $0.365B 0.00
Selecta Biosciences (SELB) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
CytomX Therapeutics (CTMX) United States $0.348B 0.00
Verastem (VSTM) United States $0.341B 0.00
ChromaDex (CDXC) United States $0.306B 0.00
Kamada (KMDA) Israel $0.302B 14.13
CorMedix Inc (CRMD) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.289B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.283B 0.00
NextCure (NXTC) United States $0.279B 0.00
IBio (IBIO) United States $0.271B 0.00
DBV Technologies S.A (DBVT) France $0.269B 0.00
AquaBounty Technologies (AQB) United States $0.261B 0.00
Pluristem Therapeutics (PSTI) Israel $0.259B 0.00
Fortress Biotech (FBIO) United States $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.253B 0.00
Aptinyx (APTX) United States $0.251B 0.00
TELA Bio (TELA) United States $0.236B 0.00
Nicox SA (NICXF) France $0.216B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.193B 0.00
Eton Pharmaceuticals (ETON) United States $0.192B 0.00
Bellus Health (BLU) Canada $0.190B 0.00
Cerecor (CERC) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Aptevo Therapeutics (APVO) United States $0.181B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.180B 0.00
Theratechnologies (THTX) Canada $0.177B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.163B 0.00
Checkpoint Therapeutics (CKPT) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.161B 0.00
SESEN BIO, INC (SESN) United States $0.160B 0.00
Abeona Therapeutics (ABEO) United States $0.160B 0.00
VolitionRX (VNRX) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.154B 0.00
Kindred Biosciences (KIN) United States $0.153B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Idera Pharmaceuticals (IDRA) United States $0.146B 0.00
TRACON Pharmaceuticals (TCON) United States $0.137B 0.00
Catalyst Biosciences (CBIO) United States $0.137B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Exicure (XCUR) United States $0.136B 0.00
Lumos Pharma (LUMO) United States $0.125B 0.00
Protalix BioTherapeutics (PLX) Israel $0.120B 0.00
Orgenesis (ORGS) United States $0.117B 243.00
Gritstone Oncology (GRTS) United States $0.115B 0.00
Applied Genetic Technologies (AGTC) United States $0.115B 0.00
Aytu Bioscience (AYTU) United States $0.113B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.112B 0.00
Cogent Biosciences (COGT) United States $0.111B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Liquidia Technologies (LQDA) United States $0.105B 0.00
DiaMedica Therapeutics (DMAC) United States $0.105B 0.00
Cyclerion Therapeutics (CYCN) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Palatin Technologies (PTN) United States $0.101B 0.00
Clearside Biomedical (CLSD) United States $0.097B 0.00
Novogen (KZIA) Australia $0.095B 0.00
Prometic Life Sciences (LMNL) Canada $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Curis (CRIS) United States $0.085B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.081B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.078B 0.00
Prima BioMed (IMMP) Australia $0.077B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Stealth BioTherapeutics (MITO) United States $0.071B 34.00
MiRagen Therapeutics (MGEN) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Soligenix (SNGX) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.064B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Seelos Therapeutics (SEEL) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Edesa Biotech (EDSA) Canada $0.049B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.045B 0.00
ATyr Pharma (LIFE) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Cleveland BioLabs (CBLI) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Titan Pharmaceuticals (TTNP) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Celsion (CLSN) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Spherix (AIKI) United States $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00